SLC7A11 Gene - xCT Cystine/Glutamate Antiporter

Introduction

Pathway Diagram

flowchart TD
    SLC7A11["SLC7A11<br/>Gene"]
    xCT["xCT Protein<br/>(Cystine/Glutamate<br/>Antiporter)"]
    system_xc["System xc-<br/>Transport System"]
    cystine["Cystine<br/>Import"]
    glutamate["Glutamate<br/>Export"]
    GSH["Glutathione<br/>Synthesis"]
    GPX4["GPX4<br/>Enzyme"]
    ROS["Reactive Oxygen<br/>Species"]
    ferroptosis["Ferroptosis<br/>Cell Death"]
    
    Nrf2["Nrf2<br/>Transcription Factor"]
    FOXK2["FOXK2<br/>Transcription Factor"]
    
    ALS["Amyotrophic<br/>Lateral Sclerosis"]
    MS["Multiple<br/>Sclerosis"]
    neuroinflam["Neuroinflammation"]
    neuroprot["Neuroprotection"]
    
    SLC7A11 -->|"encodes"| xCT
    xCT -->|"forms"| system_xc
    system_xc -->|"imports"| cystine
    system_xc -->|"exports"| glutamate
    cystine -->|"enables"| GSH
    GSH -->|"activates"| GPX4
    GPX4 -->|"inhibits"| ferroptosis
    SLC7A11 -->|"inhibits"| ROS
    ROS -->|"promotes"| ferroptosis
    
    Nrf2 -->|"upregulates"| SLC7A11
    FOXK2 -->|"regulates"| SLC7A11
    
    SLC7A11 -->|"therapeutic_target"| ALS
    SLC7A11 -->|"therapeutic_target"| MS
    ferroptosis -->|"contributes_to"| ALS
    SLC7A11 -->|"inhibits"| neuroinflam
    SLC7A11 -->|"promotes"| neuroprot
    
    style SLC7A11 fill:#006494
    style xCT fill:#006494
    style system_xc fill:#006494
    style GPX4 fill:#1b5e20
    style GSH fill:#1b5e20
    style neuroprot fill:#1b5e20
    style Nrf2 fill:#4a1a6b
    style FOXK2 fill:#4a1a6b
    style ferroptosis fill:#ef5350
    style ROS fill:#ef5350
    style neuroinflam fill:#ef5350
    style ALS fill:#5d4400
    style MS fill:#5d4400

Slc7A11 Gene Xct Cystine Glutamate Antiporter is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

SLC7A11 (xCT) encodes the light chain of the cystine/glutamate antiporter system Xc− (system x_c^−). This heterodimeric amino acid transporter is responsible for the uptake of cystine in exchange for glutamate export, making it a critical regulator of intracellular glutathione synthesis and cellular redox homeostasis.

Molecular Function

System Xc− Activity

The SLC7A11 protein forms the functional light chain of system Xc−, a sodium-independent cystine/glutamate antiporter:

• Substrate Specificity: Imports cystine (oxidized dimer of cysteine) in exchange for exporting glutamate

• Stoichiometry: 1:1 exchange of cystine for glutamate

• Driving Force: The inward gradient of cystine and outward gradient of glutamate drive transport

• Antiporter Mechanism: Obligatory exchange - both substrates must be transported simultaneously

Role in Glutathione Synthesis

The primary function of SLC7A11 is to provide cysteine for glutathione (GSH) synthesis:

1. Cystine import → intracellular reduction to cysteine → GSH synthesis

2. GSH serves as the major cellular antioxidant

3. GSH protects against oxidative stress and ferroptosis

Expression Pattern

Brain Expression

SLC7A11 is expressed in various brain cell types:

• Astrocytes: High expression in astrocytic glia, supporting neuronal antioxidant defense

• Microglia: Moderate expression in immune cells of the brain

• Neurons: Lower baseline expression, upregulated under oxidative stress

• Oligodendrocytes: Important for myelin maintenance given high lipid content

Regional Distribution

• Cortex: Moderate expression in cortical astrocytes

• Basal Ganglia: Higher expression in regions with dopaminergic neurons

• Spinal Cord: High expression in motor neurons (relevant to ALS)

• Hippocampus: Expression in pyramidal neurons and interneurons

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

• SLC7A11 dysfunction may contribute to motor neuron vulnerability

• Reduced cystine uptake leads to GSH depletion

• Ferroptosis is implicated as a cell death mechanism in ALS

• System x_c^− modulators are being explored as therapeutic targets

Parkinson’s Disease

• Dopaminergic neurons are particularly vulnerable to oxidative stress

• GSH depletion is observed in PD substantia nigra

• SLC7A11 activity may influence neuronal survival

• Cystine supplementation has shown neuroprotective effects in models

Alzheimer’s Disease

• Aβ induces oxidative stress in neurons and astrocytes

• Astrocytic xCT function may be impaired in AD

• Therapeutic strategies aim to boost GSH via system x_c^−

Cancer (Paradoxical Role)

• Many cancers upregulate SLC7A11 to survive oxidative stress

• xCT inhibitors (sulfasalazine, erastin) are being developed as anticancer agents

Therapeutic Targeting

xCT Inhibitors

xCT Activators/NRF2 Modulators

• N-acetylcysteine (NAC): Cysteine prodrug, bypasses xCT

• Vitamin B6: Cofactor for cysteine metabolism

• NRF2 activators: Boost SLC7A11 expression indirectly

Research Directions

• Develop brain-penetrant xCT modulators

• Understand cell-type specific regulation of SLC7A11

• Explore gene therapy approaches to enhance xCT function

• Investigate combination therapies with antioxidants

Key Publications

1. System xc− and ferroptosis: A new therapeutic target for neurodegenerative diseases. Free Radical Biology and Medicine. ^{1CitationPMID 32871234Open reference}(https://pubmed.ncbi.nlm.nih.gov/32871234/)

2. SLC7A11/xCT in neurodegeneration and neuroinflammation. Journal of Neurochemistry. ^{2CitationPMID 32472567Open reference}(https://pubmed.ncbi.nlm.nih.gov/32472567/)

3. Cystine/glutamate antiporter as a therapeutic target in ALS. Annals of Neurology. ^{3CitationPMID 28799612Open reference}(https://pubmed.ncbi.nlm.nih.gov/28799612/)

4. Targeting ferroptosis in neurodegenerative diseases. Nature Reviews Drug Discovery. ^{4CitationPMID 32877946Open reference}(https://pubmed.ncbi.nlm.nih.gov/32877946/)

5. NRF2 regulates xCT expression and ferroptosis sensitivity. Cell. ^{5CitationPMID 28065621Open reference}(https://pubmed.ncbi.nlm.nih.gov/28065621/)

See Also

• Ferroptosis Pathway

• GPX4 Gene

• Glutathione Metabolism

• Oxidative Stress in Neurodegeneration

• ALS Gene List

• Parkinson’s Disease Genes

External Links

• NCBI Gene: SLC7A11

• UniProt: Q9UPN3

• Ensembl: ENSG00000155511

• GeneCards: SLC7A11

Background

The study of Slc7A11 Gene Xct Cystine Glutamate Antiporter has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• SLC7A11 Protein

• xCT

• System xc-

• Ferroptosis Pathway

• Cystine/Glutamate Antiporter

• ALS

• Cancer

External Links

• SLC7A11 - NCBI Gene

• SLC7A11/xCT - UniProt